Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Qingdao Haier Biomedical Co., Ltd
  6. News
  7. Summary
    688139   CNE100003P25

QINGDAO HAIER BIOMEDICAL CO., LTD

(688139)
  Report
End-of-day quote Shanghai Stock Exchange  -  2023-02-07
69.18 CNY   -0.75%
02/04Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.
CI
02/02Qingdao Haier Biomedical Co., Ltd's Equity Buyback announced on February 7, 2022, has expired with 1,459,586 shares, representing 0.46% for CNY 99.69 million.
CI
01/04Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Beijing residents break free from COVID lockdown

11/26/2022 | 03:38pm EST

STORY: The building management had issued a notice on Thursday (November 24) after one positive case of COVID-19 was found. Residents were prevented from leaving the building and all exits were locked, including the only safety exit.

Resident Ji Zhang reported the issue to the local police.

"The property management doesn't have the right to seal the door," Zhang told Reuters.

Residents shared news and information in online groups before approaching authorities.

"The first request we have is to have a formal, legitimate document to say that ok, you are in a high-risk area, you have to quarantine," said Zoe Zhang, another resident of the building.

"If not, then they should not, A, lock down the main door and, B, if anybody has any emergency, please let us know."

Neighborhood committee staff were unable to provide legal documents supporting the measures, and the restrictions were removed.


ę Reuters 2022
All news about QINGDAO HAIER BIOMEDICAL CO., LTD
02/04Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on ..
CI
02/02Qingdao Haier Biomedical Co., Ltd's Equity Buyback announced on February 7, 2022, has e..
CI
01/04Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on ..
CI
2022Beijing residents break free from COVID lockdown
RE
2022Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Nine Months Ended S..
CI
2022Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Half Year Ended Jun..
CI
2022Basecare Medical and Haier Biomedical Join Forces to Build Cryopreservation Solutions
AQ
2022Suzhou Basecare Signs Strategic Collaboration Framework Deal with Qingdao Haier Biomedi..
MT
2022Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on ..
CI
2022Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended..
CI
More news
Financials
Sales 2022 2 862 M 422 M 422 M
Net income 2022 627 M 92,3 M 92,3 M
Net Debt 2022 - - -
P/E ratio 2022 35,0x
Yield 2022 -
Capitalization 21 943 M 3 233 M 3 233 M
Capi. / Sales 2022 7,67x
Capi. / Sales 2023 5,87x
Nbr of Employees 2 078
Free-Float 48,8%
Chart QINGDAO HAIER BIOMEDICAL CO., LTD
Duration : Period :
Qingdao Haier Biomedical Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QINGDAO HAIER BIOMEDICAL CO., LTD
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 69,18 CNY
Average target price 101,79 CNY
Spread / Average Target 47,1%
EPS Revisions
Managers and Directors
Zhan Jie Liu General Manager & Director
Rui Juan Mo Chief Financial Officer
Li Xia Tan Chairman
Xue Juan Zhang Chairman-Supervisory Board
Jiang Tao Zhang Chief Engineer
Sector and Competitors